在神经病变患者中重复使用多西环林治疗:全国性,基于人口,基于注册,匹配的队列研究
Malte M Tetens1, Lars Haukali Omland1, Ram B Dessau2,3
1Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Infectious diseases (London, England)
|July 1, 2024
概括
患有神经病变的患者在初始治疗后经常接受额外的多西环林,特别是在一年内. 这种模式建议治疗持续症状,而不是寻求一般医疗保健的行为改变.
科学领域:
- 传染性疾病 传染性疾病
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经病变,莱姆病的神经表现,需要抗生素治疗.
- 治疗后的症状可能很难管理,可能会导致进一步的医疗干预.
- 了解抗生素再处方模式对于优化患者护理至关重要.
研究的目的:
- 为了研究在初始抗生素治疗后被诊断为神经病的患者中随后接受抗生素的比例.
- 区分抗生素用于持续性神经病变症状和其他寻求医疗保健的行为.
主要方法:
- 从2009年到2021年,丹麦进行了一项全国性的基于人口的队列研究.
- 最初接受过多西环林治疗的确诊神经病变的患者与匹配的一般人群队列进行了比较.
- 随后接受多西环素和氧甲青素的情况使用危险比率进行了分析.
主要成果:
- 与对照组相比,患有神经病变的患者在一年内 (HR: 38.6) 和一年后 (HR: 3.5) 显著增加了接受额外的多西环林的患者.
- 与对照组相比,在神经病患者中没有观察到增加了氧甲基尼西林的接收.
- 这些发现被调整为潜在的混因素,如寻求医疗保健的行为.
结论:
- 患有神经病变的患者随后使用多西环林的比例很高,特别是在治疗后的第一年内.
- 与未改变的氧甲基尼西林使用相比,多西环素重新处方的特定模式表明治疗持久症状.
- 这项研究强调了需要仔细管理治疗后神经病变的症状.
相关概念视频
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
527
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
527
01:28Infectious Diseases and Their Occurrence
94
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
94
01:23Investigation of Disease Outbreaks
74
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
74